Park Yongkuk, Kim Hyejin, Lee Jong Bum
Department of Chemical Engineering, University of Seoul, 163 Seoulsiripdaero, Dongdaemungu, Seoul 130-743, Korea.
ACS Biomater Sci Eng. 2016 Apr 11;2(4):616-624. doi: 10.1021/acsbiomaterials.5b00554. Epub 2016 Mar 30.
Nucleic acid-based therapeutics are being used increasingly for biomedical applications. Despite this, the development of nontoxic and cell-targetable delivery systems for practical use is still a challenge. This paper reports a novel enzymatic synthetic approach to produce cell-targetable RNA nanovectors. The RNA nanovectors were generated by the hybridization of DNA and RNA strands produced by temperature-dependent dual polymerization, which is also called stepwise dual enzyme polymerization. The RNA strands are designed to contain siRNA precursors, and the DNA strands include aptamers that bind specifically to the target molecules for cell-targeting. The RNA nanovector can also enhance the resistance to nuclease degradation and help overcome the limitations associated with the nature of RNA via DNA-RNA hybrids. Therefore, the proposed strategy, stepwise dual enzyme polymerization, is an innovative solution for successful carrier-free siRNA delivery.
基于核酸的疗法在生物医学应用中越来越多地被使用。尽管如此,开发用于实际应用的无毒且可细胞靶向的递送系统仍然是一项挑战。本文报道了一种生产可细胞靶向RNA纳米载体的新型酶促合成方法。RNA纳米载体是通过温度依赖性双聚合产生的DNA和RNA链杂交生成的,这也称为逐步双酶聚合。RNA链被设计为包含siRNA前体,而DNA链包括与用于细胞靶向的靶分子特异性结合的适体。RNA纳米载体还可以增强对核酸酶降解的抗性,并通过DNA-RNA杂交体帮助克服与RNA性质相关的限制。因此,所提出的逐步双酶聚合策略是成功实现无载体siRNA递送的创新解决方案。